Sensus Healthcare, Inc.
SRTS
$3.30
$0.072.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -53.39% | -42.94% | -34.26% | -13.80% | 3.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -53.39% | -42.94% | -34.26% | -13.80% | 3.29% |
| Cost of Revenue | -37.99% | -19.22% | -10.13% | 14.74% | 24.19% |
| Gross Profit | -67.50% | -61.56% | -51.43% | -32.12% | -10.51% |
| SG&A Expenses | -8.60% | 0.66% | 18.72% | 52.29% | 47.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.99% | -6.45% | 12.07% | 39.75% | 39.96% |
| Operating Income | -868.93% | -570.00% | -227.39% | -145.49% | -116.00% |
| Income Before Tax | -2,480.89% | -429.43% | -206.67% | -136.32% | -105.17% |
| Income Tax Expenses | 682.87% | -318.46% | -180.21% | -146.88% | -87.62% |
| Earnings from Continuing Operations | -1,726.06% | -531.59% | -216.13% | -132.28% | -112.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,726.06% | -531.59% | -216.13% | -132.28% | -112.76% |
| EBIT | -868.93% | -570.00% | -227.39% | -145.49% | -116.00% |
| EBITDA | -1,131.77% | -513.30% | -219.10% | -141.67% | -111.91% |
| EPS Basic | -1,716.57% | -529.68% | -216.00% | -132.21% | -112.72% |
| Normalized Basic EPS | -2,460.32% | -428.30% | -206.63% | -136.27% | -105.20% |
| EPS Diluted | -1,505.26% | -561.35% | -218.46% | -133.30% | -114.46% |
| Normalized Diluted EPS | -2,394.33% | -430.05% | -206.87% | -136.38% | -105.34% |
| Average Basic Shares Outstanding | 0.39% | 0.20% | 0.09% | 0.20% | 0.28% |
| Average Diluted Shares Outstanding | 0.19% | -0.05% | -0.20% | 0.24% | 0.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |